BridgeMD
New treatment option for Stroke (Subacute)
Official title Comparative Effects of Functional Electrical Stimulation and Mirror Therapy for Foot Clearance Among Patients With Sub-acute Stroke
ClinicalTrials.gov ID: NCT07448532
What this study is testing
- What it's testing
- This study aims to evaluate the effectiveness of two rehabilitation techniques- Functional Electrical Stimulation (FES) and Mirror Therapy (MT)-in improving motor recovery among stroke survivors. Stroke often results in long-term impairments, particularly in foot clearance, which is critical for daily activities.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 85
You may be able to join if
- Patient aged 18-85 years of age, who experienced stroke within ≤6 months.
- The Fugl-Meyer motor assessment of lower extremity (FMA-LE) was conducted by physiotherapist in the hospital, and score required to be ≥ 20 points.
- Participants possessed healthy nerves, neuromuscular junctions, muscles tissues, and a sufficient range of motion in dorsiflexor and plantarflexion.
- The people could walk independently on a treadmill for at least 2 min without without experiencing adverse reaction to FES.
- Patients who received more 24 scores on Mini Mental State Exam and could comprehend and follow the information researcher provides.
You likely can't join if
- Patients with cardiac pacemaker, those with skin lesions, who could not be treated due to spasticity within the last three months, and vestibular and...
- Patients with past or current epilepsy, uncontrolled seizure disorder, mental disorders and all neurological disorders except stroke.
- Patients with severe edema of lower extremities or patients of vascular disorders like deep vein thrombosis or thromboembolisms and severe...
- people with any musculoskeletal dysfunction that would potentially affect gait and causes risk of falls.
- We excluded patients with pregnancy, plantar flexion contracture, and severe hemi-neglect.
- people with hip or knee prostheses made of metal on the lower limb were excluded.
See the full eligibility criteria
- Patient aged 18-85 years of age, who experienced stroke within ≤6 months.
- The Fugl-Meyer motor assessment of lower extremity (FMA-LE) was conducted by physiotherapist in the hospital, and score required to be ≥ 20 points.
- Participants possessed healthy nerves, neuromuscular junctions, muscles tissues, and a sufficient range of motion in dorsiflexor and plantarflexion.
- The people could walk independently on a treadmill for at least 2 min without without experiencing adverse reaction to FES.
- Patients who received more 24 scores on Mini Mental State Exam and could comprehend and follow the information researcher provides.
- No orthopedic diseases in upper and lower extremities.
- Patients with functional ambulation classification (FAC) score of 3 or 4 were included (FAC is a scale of 0-5, where 3 indicates supervision or standby guarding and 4 indicates independent on level surfaces.
- Patients with inadequate ankle dorsiflexion during the swing phase of gait.
- Patients with adequate minimal stability at the ankle during stance with stimulation.
- Patients with cardiac pacemaker, those with skin lesions, who could not be treated due to spasticity within the last three months, and vestibular and cerebellar lesions or deaf- blindness were excluded.
- Patients with past or current epilepsy, uncontrolled seizure disorder, mental disorders and all neurological disorders except stroke.
- Patients with severe edema of lower extremities or patients of vascular disorders like deep vein thrombosis or thromboembolisms and severe atheroscelerosis of lower extremities.
- people with any musculoskeletal dysfunction that would potentially affect gait and causes risk of falls.
- We excluded patients with pregnancy, plantar flexion contracture, and severe hemi-neglect.
- people with hip or knee prostheses made of metal on the lower limb were excluded.
The study team makes the final eligibility decision.
Where it's taking place
- Lahore, Punjab Province, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lahore, Punjab Province, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.